Cisco
CSCO
Disney
DIS
Adobe
ADBE
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
IBIO iBio Inc
- 5.0500
- +1.2900+34.31%
Close Feb 27 16:00 ET
- 4.9500
- -0.1000-1.98%
Post 19:59 ET
49.87MMarket Cap2.95P/E (TTM)
5.2000High3.7000Low4.97MVolume3.7900Open3.7600Pre Close23.29MTurnover57.83%Turnover RatioLossP/E (Static)9.87MShares5.200052wk High3.59P/B43.43MFloat Cap1.050052wk Low--Dividend TTM8.60MShs Float30300.0000Historical High--Div YieldTTM39.89%Amplitude1.0214Historical Low4.6820Avg Price1Lot Size
iBio Inc News
IBio: to Begin Trading on the Nasdaq Stk Exchange
IBio: Expects to Begin Trading as a Nasdaq-Listed Co on Mar 4, Continue to Trade Under 'IBIO' >IBIO
IBio: Stk Approved for Listing on Nasdaq Cap Market, Will Transfer Listing to Nasdaq From NYSE Amer >IBIO
Express News | Ibio to Begin Trading on the Nasdaq Stock Exchange
IBio to Begin Trading on the Nasdaq Stock Exchange
Ibio Inc Faces Financial Risk From Potential Stockholder Equity Dilution and Capital Raising Challenges
IBio GAAP EPS of -$0.48
Express News | IBio Q2 EPS $(0.48) Misses $(0.32) Estimate, Sales $200.00K
iBio Inc | 10-Q: Q2 2025 Earnings Report
iBio Inc | 8-K: iBio Reports Fiscal Second Quarter 2025 Financial Results
Press Release: IBio Reports Fiscal Second Quarter 2025 Financial Results
The Senate has confirmed that small Kennedy is expected to become the USA Secretary of Health, leading to a drop in vaccine stocks.
The USA Senate Finance Committee narrowly approved the nomination of small Kennedy as Secretary of Health by a vote of 1. The final confirmation vote in the Senate is expected to take place next week. The swing Republican legislator who cast the critical support vote stated that in order to gain his support, small Kennedy and the Trump administration agreed to make several concessions, including a commitment to maintain the current federal government vaccine recommendations.
IBio Files for Secondary Offering
Cutting-Edge Cancer Therapies Lead the Way Into a Transformative Year
Insider Purchase: Chief Financial Officer of $IBIO (IBIO) Buys 9,191 Shares
Press Release: IBio Announces New Investments From Board Members and Officers
Express News | Ibio Announces New Investments From Board Members and Officers
Express News | Ibio Discovers Novel Antibody Targeting Activin E in Collaboration With Astralbio
IBio Discovers Novel Antibody Targeting Activin E in Collaboration With AstralBio
iBio (IBIO.US) has obtained the license for the iBio-600 antibody, which will expand the cardiac metabolism and obesity treatment program.
iBio (IBIO.US) announced on Thursday that it has obtained the license for long-acting myostatin-inhibitory antibodies from AstralBio, thereby expanding its cardiovascular metabolism and obesity treatment development projects.
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.